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Objectives: Prompt Mental Health Care (PMHC) is the Norwegian version of the
England’s Improving Access to Psychological Therapies (IAPT). Both programs have
been associated with substantial symptom reductions from pre- to post-treatment. The
present study extends these findings by investigating symptom levels at 12 months
post-treatment, as well as treatment outcome in relation to low- vs. high-intensity
treatment forms.
Design and Outcome Measures: A prospective cohort design was used. All
participants (n = 1530) were asked to complete the Patient Health Questionnaire-9
(PHQ-9) and the Generalized Anxiety Disorder-7 questionnaire (GAD-7) at baseline,
before each session during treatment, at final treatment, and at 12 months post-
treatment. Cohen’s d was used as effect size measure. Sensitivity analyses were
conducted to examine the impact of the high missing data rates at post-treatment
(≈44%) and 12 months post-treatment (≈58%).
Results: A large symptom reduction was seen from baseline to 12 months post-
treatment for both PHQ (d = −0.98) and GAD (d = −0.94). Improvements observed at
post-treatment were largely maintained at 12 months post-treatment (PHQ (1d = 0.10)
and GAD (1d = 0.09). Recovery rates decreased only slightly from 49.5% at post-
treatment to 45.0% at follow-up. Both low- and high-intensity treatment forms were
associated with substantial and lasting symptoms reductions (−1.26 ≤ d ≤ −0.73).
Sensitivity analyses did not substantially alter the main results.
Conclusion: The findings suggest long-lasting effects of the PMHC program and
encourage the use of low-intensity treatment forms in PMHC like settings.
Keywords: prompt mental health care, CBT, anxiety, depression, IAPT, real-life settings, long-term follow-up
Abbreviations: CBT, cognitive behavioral therapy; CI, confidence interval; ES, effect size; FU, follow-up; GAD, generalized
anxiety disorder scale; GP, general practitioner; IAPT, increased access to psychological therapy; ITT, intention to treat
sample; LOCF, last observation carried forward; MAR, missing at random; MCAR, missing completely at random; MNAR,
missing not at random; NICE, National Institute for Health and Care Excellence; PHQ, patient health questionnaire; PMHC,
prompt mental health care.
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INTRODUCTION
In 2006, “The depression report, A New Deal for Depression and
Anxiety Disorders” by The Centre for Economic Performance’s
Mental Health Policy Group gave compelling reasoning for
upscaling the offer of evidence-based psychological therapy for
individuals with anxiety and depression in England (Layard et al.,
2006). The report takes us through how tremendous amounts
of people experience clinically significant levels of anxiety and
depression, how most are not treated – despite the existence
of effective, evidence-based treatment, and finally, how such
treatment would be cost-effective (Layard et al., 2006).
Aiming to improve access to evidence-based treatment for
adults with anxiety disorders and depression in England, the
program “Improving Access to Psychological Therapies” (IAPT)
was initiated (Layard et al., 2006; Parry et al., 2011; Department
of Health, 2012; Clark, 2018). IAPT provides treatment based
on National Institute for Health and Care Excellence (NICE)
guidelines, and utilizes both low intensity (e.g., guided self-
help) and high intensity [e.g., individual cognitive behavioral
therapy (CBT)] treatment forms (Clark et al., 2009; Chan and
Adams, 2014; Clark, 2018). The program was first tested at
two demonstrations sites, Doncaster and Newham (Clark et al.,
2009; Parry et al., 2011), with promising results. About 55% of
clients who had attended at least two sessions were classified
as recovered when they left the services (Clark et al., 2009).
Now the program has been established in virtually all Clinical
Commissioning Groups in England, and the latest annual report
showed that more than a million people are seen each year with
an average recovery rate of 50.8% (NHS Digital, 2018).
Also in Norway, anxiety and depression are common in the
adult population (Folkehelseinstituttet, 2018), important causes
of functional impairment, sickness absence and disability pension
(Gjesdal et al., 2008; Knudsen et al., 2010, 2012, 2013), and
associated with high levels of disease burden (Global Burden of
Disease Study 2013 Collaborators, 2015). Further, as in many
other countries (Kohn et al., 2004; Thornicroft et al., 2017; Alonso
et al., 2018), a large proportion of individuals experiencing
anxiety and depression, are not being treated (Torvik et al.,
2018). In order to address this, the Norwegian Ministry of Health
and Care Services initiated an adapted version of the IAPT,
“Prompt Mental Health Care” (PMHC, “Rask Psykisk Helsehjelp”
in Norwegian), as a pilot project in 2012 (Helsedirektoratet,
2013; Smith et al., 2016). Like IAPT, the program is a free of
charge, low threshold service aiming at short waiting times and
requiring no referral from GP’s or other health care personnel
(Helsedirektoratet, 2013; Smith et al., 2016).
The initial results from PMHC are promising, showing a
large symptom reduction from baseline to final treatment (Smith
et al., 2017; Knapstad et al., 2018). Effect sizes for both anxiety
and depression were found to be around 1 (Smith et al., 2017;
Knapstad et al., 2018), and recovery rates in line with the initial
IAPT results from Doncaster and Newham (Parry et al., 2011;
Smith et al., 2017). As these results are based on pilot cohort
data with no comparison group, they should be interpreted with
caution. However, previous randomized controlled trials with
waitlist control groups have shown that spontaneous recovery
rates tend to be high (>50%) for individuals with a relatively
recent onset (<6 months) of anxiety and/or depression, but much
lower (5–20%) for those with a longer duration (≥6 months)
of clinically significant symptoms of anxiety and/or depression
(Barton et al., 1975; Posternak and Miller, 2001; Clark et al.,
2006). As about 80% of the PMHC clients reported symptoms
to have lasted at least 6 months prior to treatment (Smith
et al., 2016), the PMHC recovery rate was significantly higher
than expected in similar (untreated) waitlist control groups
(Knapstad et al., 2018).
Though PMHC is associated with initial improvement,
symptom development beyond final treatment has not been
reported. CBT is known to be a brief and effective treatment for
depression and anxiety (Hofmann and Smits, 2008; Otte, 2011;
Hofmann et al., 2012; Cuijpers et al., 2013), but it has been
argued that short-term treatment might not always be enough to
sustain improvement over time (Vittengl et al., 2007; Clark et al.,
2018). In England, a follow-up survey was sent to a subgroup
of clients in the two IAPT demonstration sites at least four
months after treatment termination. Recovery rates were found
to be 42% at follow-up compared to 57% at post-treatment in
Newham (n = 60), and 50% at follow-up compared to 56% at
post-treatment in Doncaster (n = 452) (Clark et al., 2009). This
indicates that treatment gains at least in part are maintaned
beyond final treatment. Examination of long-term effects is
important in order to gain more knowledge about the potential
treatment benefits for clients over time. This information can also
aid the assessment of the programs’ cost-effectiveness.
In order to improve access to care through more efficient
use of therapy resources, the use of low-intensity treatment
forms has been advocated (Layard et al., 2006). Both stepped-
and matched-care models have been proposed and are used
for several mental health complaints (Newman, 2000; Scogin
et al., 2003; Helsedirektoratet, 2013; Nordgreen et al., 2016). High
intensity treatment forms are preferably reserved for individuals
who do not benefit from, or are expected not to benefit from,
low-intensity treatment (Bower and Gilbody, 2005). Stepped-
and matched care models vary greatly with regards to type and
number of interventions, and in criteria for stepping up (van
Straten et al., 2015). In PMHC, information from the initial
assessment and client’s wishes are used to determine type and
intensity of care (Helsedirektoratet, 2013; Smith et al., 2016,
2017). This matched-care design means that the client does
not always start with low intensity treatment (Helsedirektoratet,
2013). Treatment forms used in PHMC are all based on CBT
and include individual treatment (defined as high intensity
treatment), group-based psycho-education and guided self-help
(defined as low-intensity treatments) (Helsedirektoratet, 2013;
Smith et al., 2016, 2017).
Meta-analyses indicate that low-intensity treatment forms
such as guided self-help based on CBT principles (Cuijpers et al.
2010, 2013), CBT delivered in groups (Huntley et al., 2012;
Cuijpers et al., 2013; Barkowski et al., 2016; Burlingame et al.,
2016) and computerized CBT (cCBT) (Andrews et al., 2010) are
effective treatment forms for anxiety and depression disorders.
Some studies even indicate that these treatment forms can give
treatment outcomes comparable to that of individual treatment
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(Andrews et al., 2010; Cuijpers et al., 2010, 2013; Barkowski et al.,
2016; Burlingame et al., 2016). Psycho-education for anxiety and
depression seems to give promising results, although the evidence
for group-based forms is scarce (Brown and Lewinsohn, 1984;
Donker et al., 2009).
Although it seems that low-intensity treatment forms such
as guided self-help and group-based psycho-education might
be valuable alternatives to individual CBT, it should be noted
that individuals included in studies investigating low intensity
treatment forms often are recruited as volunteers (Spek et al.,
2007; Andrews et al., 2010) and may as such not be representative
for the typical PMHC client. It is therefore important to
examine the impact of treatment forms on symptoms change
in PMHC as well.
The present study aimed to investigate how symptoms
of anxiety and depression developed from baseline to
12 months post-treatment among clients from the first 12
PMHC pilot sites. We also aimed to investigate whether
symptom changes differed by treatment form (guided self-help,
group-based psycho-education, individual CBT or a mixture of
these treatment forms).
MATERIALS AND METHODS
Pilot Sites and Procedure
The PMHC-pilots have been well described before
(Helsedirektoratet, 2013; Smith et al. 2016, 2017; Knapstad
et al., 2018). In short, the first 12 PMHC-pilot sites were
established in 2012/2013, and were located across eastern,
western and central Norway in both rural and urban areas.
Demographic profiles and population size of catchment areas
varied notably between pilot sites (Smith et al., 2016; Knapstad
et al., 2018).
Independent of the catchment area, the PMHC teams had
an average of four whole time equivalents. The teams were
multidisciplinary, and included at least one psychologist with
professional responsibility for the services. All therapists had at
least 3 years of relevant higher education, and staff completed
a 1-year training program in CBT (Knapstad et al., 2018). As
mentioned above, clients could self-refer to PMHC, or be referred
by their general practitioner (GP) or others health personnel. In
this sample, 57% were referred by health personnel while 43%
contacted PMHC themselves (Knapstad et al., 2018).
All clients participated in an initial assessment. They received
information about PMHC and the therapist assessed the
relevance and severity of mental health problems and decided
whether PMHC could be the appropriate service (Knapstad
et al., 2018). To be included, the patient had to be living
in the pilot site community, be 18 years or older and have
mental health needs related to anxiety and/or depression (no
formal diagnosis was needed or provided) (Helsedirektoratet,
2013; Knapstad et al., 2018). Clients with a history or clear
indications of psychosis, bipolar disorder, personality disorder,
severe drug abuse, or suicide risk were generally referred to their
GP or secondary health care services and not included in PMHC
(Helsedirektoratet, 2013; Knapstad et al., 2018).
Participation in the study was based on opt-in. Clients who
chose to participate signed informed consent and were asked
to complete questionnaires before treatment (baseline), before
each session during the treatment, at final treatment and at
12 months post-treatment (Knapstad et al., 2018). Participants
who dropped out of treatment were still invited to complete the
follow-up questionnaire. The median time from baseline to final
treatment was 13.4 weeks (IQR: 7.0–22.1) and the median time
from final treatment to follow-up was 55.0 weeks (IQR: 54.0–
59.4 – throughout the manuscript referred to as “12 months
post-treatment”). The Regional Ethics Committee for Western
Norway approved the study (REK-vest no. 2014/597).
Participants
In total, 2,512 clients started treatment at one of 12 the PMHC
pilot sites between October 2014 and December 2016 (Knapstad
et al., 2018). Of these, 1,530 (61%) signed informed consent and
participated in the study (a previous article reported 1532 clients
(Knapstad et al., 2018), but 2 of these cases turned out to be test
clients). The participation rate varied across pilot sites, but was
above 60% for 8 of the 12 sites (Knapstad et al., 2018). Of the
1,530 participants, 84.6% attended at least two treatment sessions.
No information was available from those who received treatment,
but did not participate.
As described previously (Knapstad et al., 2018), 75% of the
PMHC clients were female. Most (54%) were between 26 and
44 years of age and 44% had completed higher education. More
than 50% were married or cohabiting, 11% had immigrant
background, 39% were working (full or part time) with no
benefits, 35% had a job while receiving benefits, and 26%
were not working, with or without benefits. Males, individuals
over 67 years of age, individuals with lower education and
individuals with immigrant background were underrepresented
among participants compared to the population in the catchment
areas (Knapstad et al., 2018). Upon inclusion, 84% of the clients
reported their symptoms of anxiety and/or depression to have
lasted 6 months or longer (Knapstad et al., 2018).
Treatment Forms
The three main CBT-based treatment forms used in the PMHC
pilots were guided self-help, where clients were guided in the
use of self-help tools, such as literature and computer programs,
group-based psycho-education, and face-to-face, individual CBT
(Helsedirektoratet, 2013; Smith et al. 2016, 2017).
Information from the initial assessment, as well as
client’s wishes, were used to determine treatment form
(Helsedirektoratet, 2013; Smith et al., 2016, 2017). The therapists
were asked to report treatment forms used at each meeting with
the client (Smith et al., 2016).
If the therapist reported one of the above mentioned treatment
forms to have been used in at least 80% of a client’s sessions,
the client was placed in the corresponding group (guided self-
help, group-based psycho-education, or individual CBT). The
remaining clients were placed in the group “Mixed,” including
clients who went from low- to high-intensity treatment or vice
versa (Smith et al., 2016). To illustrate the latter, 36.3% of the
clients in the mixed group received individual CBT as their first
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two sessions, whereas 33.1% received low-intensity treatment as
their first two sessions.
Across pilot sites, individual CBT was the most used treatment
form (Smith et al., 2016). Still, the included pilot sites differed
in which treatment forms were most commonly used. Compared
to the other pilot sites, two sites (Fosen and Molde) more often
used guided self-help, and three pilot sites (Fjell, Notodden
and Orkdal) more often used group-based psycho-education
(Smith et al., 2016).
Clinical Outcome Measures
As in IAPT, symptoms of depression and anxiety were measured
using well-validated tools. Depressive symptoms were measured
using the Patient Health Questionnaire -9 (PHQ-9) (Kroenke
et al., 2001, 2010). Participants were asked how often during
the last 2 weeks they had experienced nine common symptoms
of depression, such as “little interest or pleasure in doing
things” and “feeling tired or having little energy.” They reported
the frequency on a scale from “not at all” (“0”) to “nearly
every day” (“3”). The PHQ-9 has been shown to have good
psychometric properties (Kroenke et al., 2001), and in our sample
the Cronbach’s alpha for the instrument was 0.85 (Knapstad et al.,
2018). A sum score was created, ranging from 0 to 27. Clients
who had not answered all items, but at least 4, got their sum score
based on the mean of the items they had responded to.
Anxiety was measured using the Generalized Anxiety
Disorder-7 (GAD-7) (Spitzer et al., 2006; Kroenke et al., 2010).
Participants were asked to rate how often during the last 2 weeks
they had experienced 7 common symptoms of anxiety, such as
“feeling nervous, anxious or on edge,” and “trouble relaxing.” The
frequency was reported on the same scale as for PHQ-9, from
“not at all” (“0”) to “nearly every day” (“3”). GAD has been found
to have good reliability and validity for measuring generalized
anxiety disorder (Spitzer et al., 2006), and to have satisfactory
sensitivity and specificity for generalized anxiety as well as other
anxiety disorders (Kroenke et al., 2007). In our sample, the
Cronbach’s alpha for the instrument was 0.87 (Knapstad et al.,
2018). A sum score was created, ranging from 0 to 21. As for
PHQ, clients who had answered at least four items got their sum
score based on the mean of the items they had responded to.
Clinical caseness was defined as having a PHQ-score ≥ 10
and/or a GAD-score ≥ 8, in line with the definition used in IAPT
(Clark et al., 2009).
Background Variables
Clients reported their gender (male, female), age (18–24, 25–
44, 45–67, > 67), education (primary school, high school,
university/university college), job status (working, working and
receiving benefits, not working with or without benefits),
marital status (living alone, not living alone) and immigrant
background (yes, no).
Clients were also asked to rate their physical activity (days
per week), their alcohol consumption (two times a week or
more, once a week or less), and smoking status (yes, no).
They also reported whether they were using antidepressant
medication (every day, not every day), sleep medication (every
week, not every week) or anxiolytic medication (every week,
not every week). The perceived cause of symptoms was also
reported (amongst others: relationship problems, school/job
related, and/or bullying).
Missing Data
As described previously, missing data rates at baseline were
generally low (Knapstad et al., 2018), and 72.5% of the clients
completed at least one follow-up questionnaire while under
treatment (not including the final treatment questionnaire).
However, the proportion of missing data was significantly higher
at final treatment and 12 months post-treatment. The proportion
of missing data at baseline, final treatment and 12 months was
1.04%, 43.5 and 57.9%, respectively, for PHQ, and 1.04, 43.7, and
59.1%, respectively, for GAD.
Missing data for PHQ and GAD at final treatment was
associated with the baseline variables age, education, reporting
the cause of current symptoms to be relationship problems or
bullying, PHQ and GAD at the p < 0.10 level in logistic regression
analyses including one predictor variable at the time, in addition
to pilot site. In subsequent multiple logistic regression analyses
only age, education and reporting the cause of current symptoms
to be bullying predicted missingness at the p < 0.05 level. The
McKelvey and Zavoina R2 was equal to 0.15. These three variables
were only weakly correlated with PHQ and GAD scores at final
treatment (r < 0.4).
Missing data for PHQ and GAD at 12 months was associated
with baseline variables age, gender, marital status, job status,
education, immigrant background, use of anxiolytic medication,
and reporting the cause of current symptoms to be relationship
problems or bullying at the p < 0.1 level in logistic regression
analyses including one predictor variable at the time, in addition
to pilot site. In subsequent multiple logistic regression analyses,
gender, age, education and reporting the cause of current
symptoms to be relationship problems or bullying predicted
missingness at the p < 0.05 level. The McKelvey and Zavoina R2
was equal to 0.07. These five variables were only weakly correlated
with PHQ and GAD scores at 12 months (r < 0.4).
These results provided some evidence that the data were partly
missing at random (MAR). It is nonetheless likely that, in these
types of settings, part of the missing data is missing not at random
(MNAR) (Enders, 2010). Non-response for some participants
may be more likely because of the actual (but unobserved)
PHQ/GAD scores at post-treatment, which is conceivable for
both those who are not improving and those recovering. The
bias introduced by MNAR can partly be eliminated by including
strong correlates of variables with missing data (Enders, 2010).
In the present study, there were relatively strong relationships
between the observed PHQ and GAD scores at post-treatment
and, respectively, baseline PHQ and GAD scores (r ≈ 0.44),
and the last observed measurement of PHQ and GAD under
treatment (r ≈ 0.73). There were also strong associations
between PHQ and GAD scores at 12 months post-treatment and,
respectively, PHQ and GAD scores at post-treatment (r ≈ 0.50),
and the last observed measurement of PHQ and GAD under
treatment (r ≈ 0.50).
Information on therapist reported treatment form was missing
for 26.7% of the clients. About 46% of the variance in missing
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therapist data was explained at the therapist level. This may
suggest that some therapists have been more conscientious in
reporting the required data than others. Cases with missing
therapist data were excluded from the analyses when treatment
form was included as an independent variable.
Missing Data and Reason for Treatment
Termination
Reasons for treatment termination were based on information
from the questionnaires that the therapists provided by the end of
treatment for each client. In 24.4% (n = 373) of the cases, no such
information was provided by the therapists. Completers (67.1%,
n = 1027) were defined as clients for whom the therapeutic goal
was achieved (49.3%, n = 754) OR clients who attended at least
six sessions (50.2%, n = 768 – note that these two criteria were
not mutually exclusive). A cut-off at six sessions was used as
this was the median number of treatment sessions for the entire
sample and as this reflects a reasonable number of sessions for
a complete short-term CBT-treatment. Forty-two clients were
categorized as completers based on having completed at least
six questionnaires during treatment even though no therapists-
reported information was available.
Clients who did not meet these criteria were categorized as
dropouts (7.3%, n = 112) or as being referred to other services
(3.9%, n = 60), depending on the information provided by
the therapists. The remaining 21.6% (n = 331) could not be
categorized by reason for treatment termination.
Table 1 shows that non-response was much higher for
dropouts, referrals and clients with missing therapist data. The
mechanisms for non-response were likely different across groups.
Not responding due to higher PHQ (or GAD) scores may be more
likely among dropouts and referrals. The observed change for
PHQ in this group was also much lower than the observed change
in the completer group. For the group with missing therapist data,
missing client data may to a lesser degree depend on actual PHQ
(or GAD) scores, but may be more strongly associated with the
degree to which the therapist committed him- or herself to the
study – as a large percentage of the variance in missing therapist
scores was explained at the therapist level. The observed change
for PHQ in this group was also more similar to the observed
change in the completer group (see Table 1).
Statistical Analyses
Stata version 15 was used for all analyses, unless otherwise stated.
Linear mixed models based on the available data from all
participants (n = 1530) were used to examine the change in
symptoms of anxiety and depression across four measurement
occasions: pre-treatment, the last observed measurement under
treatment, post-treatment, and 12 months post-treatment.
Occasion was treated as a categorical variable using 12 months
post-treatment as the reference category. Occasion was modeled
as a random intercept, whereas dependency within pilot site was
modeled as a (categorical) fixed effect. Effect sizes were calculated
by dividing the mean difference score by the standard deviation
at pre-treatment (Cohen’s d).
Mixed model analyses use maximum likelihood estimation
and can handle data that are missing at random (MAR). Although
there are no conclusive tests to prove the assumption of MAR, it is
generally considered a more realistic assumption as compared to
missing completely at random (MCAR) and provides less biased
estimates than more traditional methods such as last observation
carried forward. For clinical caseness, the STATA module gsem
was used to estimate the mixed model. The marginal probabilities
derived from this model provided a lower bound to the recovery
rate that is commonly used in IAPT reports (Clark et al., 2009;
National Health Service, 2017). Recovery rate is defined as the
proportion of the number of clients that move from being at
caseness at baseline to not at caseness at treatment termination
divided by the total number of clients at caseness at baseline. In
contrast to this definition, the gsem model did include clients
not at caseness at baseline, and the marginal probabilities should
therefore be interpreted as lower bounds for the recovery rate.
That is, if some of the participants who were not at caseness at
baseline moved to caseness at follow-up, the IAPT recovery rate
would be somewhat higher than reported in the present study
(National Health Service, 2017).
Two sensitivity analyses were conducted, using more
conservative missing data strategies for clients that terminated
treatment due to drop-out or further referral and for clients for
whom the reason for treatment termination was unknown due
to missing therapist data. The first sensitivity analysis adopted
the last-observation-carried-forward strategy in the drop-outs
and referral group (n = 172). Intuitively, this may be a realistic
approach as additional change after the last observation seems
less likely without additional treatment. The second sensitivity
analysis extended the last-observation-carried-forward method
to the group with missing information on reason for treatment
termination (n = 331). Although this may be too conservative
for this group, for reasons explained in the previous section, the
TABLE 1 | Data completeness across measurement occasions by reason for treatment termination.
Baseline Under treatment Post-treatment 12m. post-treatment 1PHQ post-treatment∗
%(n) %(n) %(n) %(n) M(SD)
All (n = 1530) 99.1(1516) 72.2(1109) 56.5(865) 42.3(647) −6.2(5.5)
By reason for tr. termination:
Completers (n = 1027) 99.8(1025) 86.3(886) 75.9(779) 50.2(516) −6.4(5.3)
Drop-outs/referrals (n = 172) 100(172) 51.7(89) 37.8(65) 27.9(48) −4.1(5.8)
Not reported (n = 331) 96.4(319) 40.4(134) 6.3(21) 25.1(83) −6.4(7.8)
∗: change in PHQ from baseline to post-treatment. M: mean change. SD: standard deviation.
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large percentage of missing data, in particular at final treatment,
warrants this approach and results could be considered as
a reasonable worst-case scenario. It should be noted that
this type of sensitivity analysis is primarily concerned with
between-analysis differences (difference between regular and
sensitivity analysis with regard to change between, for example,
baseline and 12 months post-treatment). Differences within each
sensitivity analysis across occasions become smaller and are as
such less informative with regard to the sustainability of changes
beyond post-treatment.
For outcomes PHQ and GAD, the likelihood ratio test
was used to test for the interaction between occasion
(baseline, last observation under treatment, final treatment
and 12 months post-treatment) and treatment form (self-
help, group-based, individuals and mixed). Adjusted
models were estimated to account for baseline differences
across treatment forms, including the PHQ/GAD score at
baseline. As maximum likelihood missing values (MLMV)
estimation was not available for multilevel models in Stata,
Mplus version 8 was used to estimate the adjusted models
for which baseline PHQ/GAD was used as a between-
level covariate instead of an outcome variable in the
multilevel model formulation. In order to obtain the same
number of observations as for the unadjusted models, all
covariates (see also next paragraph) were brought into
the model as dependent variables under the assumption of
multivariate normality.
Potential confounders of the association between therapy form
and symptom change were identified by running a series of
generalized linear models with treatment form as outcome and
pilot site plus one baseline variable at the time as predictors.
The association with treatment form was tested for each baseline
variable mentioned in the measures section. Clients receiving
individual CBT were set as reference category. A baseline variable
was included as covariate in the adjusted models when the
association was statistically significant at the p < 0.05 level (Wald
test). In addition, prominent predictors of change that were
identified in previous work (Knapstad et al., 2018) were included
in the adjusted analyses (job status, immigrant background,
use of antidepressant medication, use of sleep medication, and
reporting bullying as cause of problems).
RESULTS
Treatment Outcome at 12 Months
Post-treatment
As shown in Table 2, PHQ and GAD levels at 12 months
post-treatment continued to be much lower than the initial
baseline levels (dphq = -0.98 and dgad = -0.94), despite a
small increase in symptom levels from post-treatment to
12 months post-treatment (dphq = 0.10 and dgad = 0.09). This
is visualized in Figure 1, in which the estimated means are
plotted at each measurement occasion. The proportion of clients
at caseness at 12 months post-treatment was 45% lower as
compared to baseline. This should be considered as a lower-
bound for the recovery rate used in IAPT. The proportion of
clients at caseness increased with 4.5% from post-treatment to
12 months post-treatment.
The results from the first sensitivity analyses using LOCF for
drop-outs and referrals indicated somewhat lower effect sizes, but
the changes from baseline to 12 months post-treatment could
still be considered large (d > 0.8). The lower bound estimate
for recovery rate was 41.9%. The second sensitivity analyses,
using LOCF for clients with missing therapist data, indicated a
further drop in effect size estimates. The change from baseline to
12 months post-treatment remained nonetheless in the close to
large range (d ≈ 0.8). The lower bound estimate for recovery rate
dropped to 35.7%.
Treatment Forms
Of the 1110 clients for whom the therapists reported
information about treatment forms, 65.5% received
primarily individual CBT, 15.8% received primarily
group-based psychoeducation, and 7.8% received
primarily guided self-help. The remaining 11.2% clients
received a mixture of these three treatment forms. As
displayed in Figure 2, the median number of treatment
sessions was lowest for guided self-help (4, IQR = 2–
5) and group-based psychoeducation (5, IQR = 5–6),
and highest for individual CBT (6, IQR = 4–9) and
mixed (7.5, IQR = 5–11).
Baseline differences across treatment forms were identified for
age (χ2 (3) = 16.6, p < 0.001), bullying as cause of symptoms (χ2
(3) = 10.3, p = 0.02), and symptoms of anxiety (χ2 (3) = 13.6,
p = 0.004). Clients receiving guided self-help or group-based
psycho-education were on average older (≈40 vs. 37.0 years), and
had lower average anxiety scores (≈9 vs. 10.2) as compared to
those receiving individual CBT. Clients receiving group-based
psycho-education more frequently reported bullying as cause
of their symptoms as compared to clients receiving individual
CBT (18.6% vs. 10.0%). Clients in the mixed group had higher
average scores on anxiety compared to the individual CBT
group (11.0 vs. 10.2).
Treatment Outcome by Treatment Form
The likelihood-ratio test was statistically significant for both
PHQ (χ2 (9) = 43.5, p < 0.001) and GAD (χ2 (9) = 55.8,
p < 0.001), indicating different symptom trajectories across
treatment forms. As shown in Table 3, the overall decrease in
symptoms of depression and anxiety from baseline to 12 months
post-treatment was large (d > 0.8) for all treatment forms.
However, the estimated improvement was smaller for guided self-
help (d = −0.88) and group-based psychoeducation (d = −0.87)
as compared to individual CBT (d = −1.01). The estimated scores
at 12 months post-treatment were not statistically different from
each other, but this is likely due to lack of power as a consequence
of substantial non-response at this occasion.
Guided self-help was associated with a clinically significant
increase in symptoms of depression and anxiety from post-
treatment to 12 months post-treatment (dphq = 0.41, dgad = 0.46),
although this deterioration was not significantly different from
the change between these two occasions for individual CBT
(dphq = 0.12, dgad = 0.12). Again, this may be due to lack of power.
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TABLE 2 | Change estimates using 12 months post-treatment as reference.
12m. post-treatment vs. Baseline 12m. post-treatment vs. Post-treatment
Outcomes Change 95% CI p-value Effect size Change 95% CI p-value Effect size
MAR-based analyses
PHQ −5.58 −5.93,−5.22 < 0.001 −0.98 0.54 0.15,0.93 0.006 0.10
GAD −4.69 −5.01,−4.37 < 0.001 −0.94 0.47 0.12,0.82 0.008 0.09
Clinical caseness −3.60 −3.98,−3.22 < 0.001 −45.0%∗ 0.41 0.08,0.73 0.015 4.5%†
Sensitivity analyses 1
PHQ −5.13 −5.45,−4.81 < 0.001 −0.90 0.46 0.12,0.81 0.009 0.08
GAD −4.32 −4.61,−4.04 < 0.001 −0.86 0.40 0.09,0.71 0.011 0.08
Clinical caseness −3.76 −4.15,−3.38 < 0.001 −41.9%∗ 0.30 −0.01,0.61 0.057 3.1%†
Sensitivity analyses 2
PHQ −4.38 −4.66,−4.11 < 0.001 −0.77 0.23 −0.05,0.51 0.110 0.04
GAD −3.72 −3.96,−3.47 < 0.001 −0.74 0.19 −0.06,0.44 0.139 0.04
Clinical caseness −4.08 −4.48,−3.68 < 0.001 −35.7%∗ 0.14 −0.15,0.43 0.337 1.4%†
MAR-based analyses: Linear mixed models assuming missing at random. Sensitivity analyses 1: LOCF strategy applied to drop-outs and those referred to other
services (n = 172); Sensitivity analyses 2: LOCF strategy also applied to those for whom the reason for treatment termination was unknown (n = 331). ∗Proportion
at caseness at 12 months post-treatment minus proportion at caseness at baseline. †Proportion at caseness at 12 months post-treatment minus proportion at caseness
at post-treatment.
FIGURE 1 | Course of anxiety and depression from baseline to 12 months post-treatment.
Symptom levels were stable from post-treatment to 12 months
post-treatment for the psycho-education group, whereas the
mixed group improved somewhat further on symptoms of
depression (d = −0.20). For depressive symptoms, this change
was significantly different from the estimated change in the
individual CBT group.
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FIGURE 2 | Box plot of number of sessions by treatment form.
TABLE 3 | Estimated scores at 12 months post-treatment and associated change compared to post-treatment and baseline by treatment form.
Estimated score at 12m.
post-treatment

















Guided self-help 7.57(84) 7.30 (5.60, 9.00) 8.05 (6.56, 9.54) 1.97 (0.42, 3.52) 0.41 1.92 (0.45, 3.39) −4.23 (−5.87, -2.58)∗ −0.88
Group-based
psychoed.
15.77(175) 7.04 (5.89, 8.18) 7.27 (6.21, 8.33) −0.27 (−1.35, 0.80) −0.06 −0.07 (−1.12, 0.98) −4.63 (−5.80, -3.45)∗ −0.87
Mixed 11.17(124) 5.80 (4.64, 6.95) 5.75 (4.71, 6.79) −1.10 (−2.26, 0.07)∗∗ −0.20 −0.92 (−2.06, 0.21)∗∗ −7.08 (−8.45, -5.70) −1.26
Individual CBT (Ref.) 65.50(727) 6.57 (6.03, 7.12) 6.64 (6.13, 7.15) 0.71 (0.20, 1.23) 0.12 0.71 (0.20, 1.22) −5.97 (−6.55, -5.39) −1.01
GAD
Guided self-help 7.57(84) 5.63 (4.00, 7.30) 6.27 (4.71, 7.83) 2.06 (0.45, 3.67) 0.46 2.13 (0.46, 3.80) −3.44 (−4.84, -2.05)∗ −0.76
Group-based
psychoed.
15.77(175) 5.54 (4.65, 6.44) 5.80 (5.00, 6.61) −0.31 (−1.24, 0.63) −0.07 −0.24 (−1.15, 0.68) −3.41 (−4.33, -2.49)∗∗ −0.73
Mixed 11.17(124) 4.89 (3.93, 5.86) 4.50 (3.62, 5.37) −0.43 (−1.41, 0.54) −0.08 −0.38 (−1.36, 0.60) −6.04 (−7.10, -4.98) −1.18
Individual CBT (Ref.) 65.50(727) 5.27 (4.79, 5.73) 5.34 (4.90, 5.79) 0.56 (0.10, 1.02) 0.12 0.58 (0.13, 1.03) −5.01 (−5.53, -4.49) −1.04
∗∗Difference compared to individual CBT is significant at the p < 0.01 level. ∗Difference compared to individual CBT is significant at the p < 0.05 level. Variables included
in the adjusted analyses: age, bullying as cause of problems, antidepressant medication, sleep medication, immigrant background, job status, and baseline PHQ/GAD
(all grand mean centered). Effect size = unadjusted estimate/observed SD within treatment group.
Adjusting for baseline differences across treatment
forms and predictors of change did not alter the results
substantially (Table 3).
DISCUSSION
Our findings indicate that improvements observed at post-
treatment were largely maintained at 12 months post-treatment,
despite a small, but statistically significant, increase in symptom
levels. This is illustrated by estimated (lower bound) recovery
rates being 49.5% at post-treatment and 45% at 12 months
post-treatment. These findings are in line with a sub-group
investigation from IAPT indicating that symptom improvement
lasts beyond final treatment (Clark et al., 2009).
The sensitivity analyses also pointed to large and maintained
decreases in symptoms of anxiety and depression at 12 months
post-treatment. Given the level of missing data in the present
study, carrying out sensitivity analyses is important. However,
finding reasonable assumptions for these analyses is a challenging
task, and can dramatically affect results (Enders, 2010). This
seems especially true when there are high rates of missingness.
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In the present study, LOCF strategies were applied to clients who
did not complete treatment and clients with unknown reason
for treatment termination. The latter was used as a reasonable
worst case scenario, and affected about one third of the sample.
Also under these more conservative assumptions, the estimated
change from baseline at 12 months post-treatment remained
large. Although these sensitive analyses are useful in order to
get an idea of the potential bandwidth of the estimates in the
presence of MNAR, it’s important to keep in mind that maximum
likelihood estimation, which we used for the primary analyses, is
generally considered one of the preferred methods to analyze data
with missing values, also in the presence of MNAR data (Siddiqui
et al., 2009; Crameri et al., 2015).
Previous research has shown that low-intensity treatment
forms can be effective for anxiety and depression (McDermut
et al., 2001; Andrews et al., 2010; Cuijpers et al., 2010; Huntley
et al., 2012; Cuijpers et al., 2013; Barkowski et al., 2016;
Burlingame et al., 2016), though the evidence for group-based
psycho-education is scarce (Brown and Lewinsohn, 1984; Donker
et al., 2009). Our results showed that all treatment forms
(guided self-help, group-based psycho-education, individual
CBT and a mix of treatment forms) were associated with a
large symptom reduction from baseline to 12 months post-
treatment, although the low-intensity treatments were associated
with a somewhat smaller reduction in symptom levels. Moreover,
changes in symptoms from post-treatment to 12 months post-
treatment were generally small across treatment forms. A notable
exception was guided self-help, which was associated with a
clinically significant increase in symptoms from post-treatment
to 12 months post-treatment. By design, it’s difficult to determine
whether the latter change is related to the actual treatment or
to other client and/or therapist characteristics. Future studies
should examine this potential problem in more detail. Overall,
our results were in line with findings from IAPT which also found
that both low and high intensity treatments were associated with
a large reduction in symptoms from pre- to post-treatment (Chan
and Adams, 2014). The current study extends these findings
across treatment forms to results at long-term follow-up.
Neither in IAPT or in the current evaluation of PMHC,
clients were randomized to treatment forms. In PMHC,
client’s wishes and site preferences were decisive for treatment
allocation. Our findings should therefore be interpreted with
caution. To be able to provide unbiased comparisons of the
effects across treatment forms, an equivalence or a non-
inferiority trial should be considered. Nonetheless, that these
treatment forms are associated with substantial improvement
when employed to willing clients is also valuable information.
In addition, baseline differences across treatment forms were not
statistically significant for the majority of background variables,
and accounting for significant differences did not alter the results.
The differences in changes across treatment forms can therefore
not be attributed to the included background variables, which to
a certain extent increases the validity of our results.
The long-term, large reduction in symptoms associated with
low-intensity treatment calls for an increased use of these
treatments in PMHC, also as this study confirmed that these
treatment forms were in fact low-intensity in terms of number of
sessions used. Although frequent use of low-intensity treatment
forms was an initial goal of PMHC (Smith et al., 2016), individual
CBT was by far the most used treatment form across pilot
sites (Smith et al., 2016; Knapstad et al., 2018). As discussed
earlier (Smith et al., 2016; Knapstad et al., 2018), this might be
related to therapists being primarily trained for individual, face-
to-face treatment. Therapists may as such have been inclined to
use face-to-face treatment instead of low-intensity treatments.
Therefore, allocation to treatment may not have been solely
based on information from the initial assessment and client‘s
preferences, but also on therapist’s preferences. Also, guided self-
help programs and group course materials were not available
when the PMHC pilots started up. Considerable time and
resources were required for development of material at local pilot
sites, delaying and sometimes hampering implementation and
use of low-intensity treatments (Smith et al., 2016; Knapstad et al.,
2018). Moreover, use of guided self-help was not experienced
as low-intensive by some therapists (Smith et al., 2016). In
the light of these limitations reported at the pilot sites, the
symptom improvement associated with low-intensity treatments
can be considered promising. In order to increase the use of
low-intensity treatments, and as such enable up-scaling and
improvement of the cost-effectiveness of PMHC, evidence-based
programs for guided self-help and group courses should be made
more readily available. Evidence for the effectiveness of internet
and other electronic interventions is also growing (Andrews et al.,
2010), and may also have great potential for PMHC.
Strengths and Limitations
An important limitation of the study is related to drop-out
and missing data. Missing data rates were low at baseline,
but high at final treatment and 12 months post-treatment. At
12 months post-treatment there was above 50% missing for the
outcome measures of interest. This may have introduced bias.
A compensating strength of the study was the use of the state-
of-the-art methods to deal with these missing data. High levels of
missing data also reduced power. In particular the power to detect
meaningful differences between treatment forms was probably
affected by this.
Additionally, two sensitivity analyses were performed to
examine the potential impact of MNAR. The more realistic one
of these two analyses, in which missing data among those who
dropped out or were referred to other services were imputed by
means of LOCF, indicated only a small decrease in change score
estimates. This strengthens the finding from the main analyses;
PMHC is associated with substantial and long-term improvement
in terms of symptoms of anxiety and depression.
High attrition rates, in combination with a relatively low
participation rate, resulted in a low overall response rate at
12 months post-treatment of about 25% (0.41 ∗0.61 ≈0.25). This
limits the generalizability of the current findings. Although data
for non-participants were unavailable, some selection among
participants seems reasonable to assume (e.g., more females,
less severe symptoms at baseline), which may potentially have
affected the outcome estimates presented in the current paper.
Our analyses are based on cohort data from the first
12 PMHC pilot sites, and no control group was included.
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Though spontaneous recovery may be less likely in the
PMHC sample, because the majority of participants reported
symptoms to have lasted for at least 6 months prior to
treatment, the initiated randomized controlled trial of PMHC
(ClinicalTrials.gov Identifier: NCT03238872) will be of great
value in demonstrating more precisely the short and long-term
effects attributable to PMHC.
Guided self-help has been a core element from the start in
the English and Australian versions of IAPT. It’s therefore likely
that the pre-post treatment results of guided self-help in these
countries are based on samples that included a broader range of
clients as compared to the Norwegian sample. As such, our results
may not generalize to IAPT programs that have guided self-help
as primary mode of treatment.
Strengths of this study included a relatively large sample
size, enabling investigation of treatment outcomes 12 months
after final treatment, and comparison of treatment outcomes
across treatment forms. Also, clinical outcomes were investigated
using well-validated instruments (Kroenke et al., 2001, 2010;
Spitzer et al., 2006). Finally, the pragmatic focus provides an
encouraging demonstration of how treatments developed in
controlled settings can be effective in a routine health care system.
CONCLUSION
This study shows that improvement in symptoms of anxiety
and depression achieved from baseline to post-treatment in
PMHC were not temporary only. Both overall and across
treatment forms, the change in symptom load from PMHC
entry to 12 months post-treatment was large. As such, both
low- and high-intensive treatment forms seem to be viable
alternatives to help people who suffer from symptoms of anxiety
and depression, even though the changes associated with low-
intensity treatment forms were somewhat smaller. In order
to improve cost-effectiveness of PMHC, increased use of low-
intensity treatment forms, such as guided self-help and group-
based psychoeducation, should be considered in the further roll-
out of the service. Continuous monitoring of effectiveness should
also be considered.
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